These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3829004

  • 1. Varying probability of the development of acute nonlymphoblastic leukemia in refractory anemia patients with an excess of blasts.
    Oguma S, Yoshida Y, Uchino H, Maekawa T.
    Cancer Res; 1987 Apr 15; 47(8):2196-8. PubMed ID: 3829004
    [Abstract] [Full Text] [Related]

  • 2. Factors influencing leukemic transformation in refractory anemias with excess of blasts, with ringed sideroblasts, and without ringed sideroblasts.
    Oguma S, Yoshida Y, Uchino H, Maekawa T.
    Cancer Res; 1986 Jul 15; 46(7):3698-700. PubMed ID: 3458528
    [Abstract] [Full Text] [Related]

  • 3. Blast counts in bone marrow aspirate smears: analysis using the poisson probability function, bayes theorem, and information theory.
    Vollmer RT.
    Am J Clin Pathol; 2009 Feb 15; 131(2):183-8. PubMed ID: 19141378
    [Abstract] [Full Text] [Related]

  • 4. Factors influencing nonleukemic death in refractory anemia, refractory anemia with ring sideroblasts, and refractory anemia with excess of blasts.
    Oguma S, Yoshida Y, Uchino H, Maekawa T.
    Cancer Res; 1987 Jul 01; 47(13):3599-602. PubMed ID: 3581090
    [Abstract] [Full Text] [Related]

  • 5. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH, Kantarjian HM, O'Brien S, Kornblau S, Andreeff M, Beran M, Pierce S, Keating M.
    Cytokines Mol Ther; 1995 Mar 01; 1(1):21-8. PubMed ID: 9384660
    [Abstract] [Full Text] [Related]

  • 6. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y.
    Oncologist; 1996 Mar 01; 1(4):284-287. PubMed ID: 10388004
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Percentages of bone marrow blasts and chromosomal changes in patients with refractory anemia help to determine prognoses.
    Iwabuchi A, Ohyashiki K, Ohyashiki JH, Kimura Y, Lin KY, Aizawa S, Nehashi Y, Miyazawa K, Yaguchi M, Toyama K.
    Int J Hematol; 1994 Oct 01; 60(3):207-13. PubMed ID: 7858240
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Cutaneous leukemia in refractory anemia with an excess of blasts in transformation].
    Mestre F, Pinazo I, Betlloch I, Mas JM, Galmes A, Buades J.
    Ann Dermatol Venereol; 1988 Oct 01; 115(12):1265-9. PubMed ID: 3071964
    [No Abstract] [Full Text] [Related]

  • 11. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K.
    Leuk Res; 2004 Jun 01; 28(6):587-94. PubMed ID: 15120935
    [Abstract] [Full Text] [Related]

  • 12. A case of refractory anemia with excess of blasts evolving to acute myelomonocytic leukemia studied with monoclonal antibodies.
    Büchi G, Girotto M, Termine G, Ganio D, Gario S, Grosso E, Autino R, Zappalà C.
    Haematologica; 1987 Jun 01; 72(5):455-7. PubMed ID: 3121469
    [No Abstract] [Full Text] [Related]

  • 13. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Eur J Haematol; 2004 Feb 01; 72(2):89-106. PubMed ID: 14962246
    [Abstract] [Full Text] [Related]

  • 14. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H, Haas PS, Kunzmann R, Schulte-Mönting J, Lübbert M.
    Ann Hematol; 2006 Aug 01; 85(8):502-13. PubMed ID: 16715299
    [Abstract] [Full Text] [Related]

  • 15. Secondary refractory anemia with excess of blasts in transformation terminating as acute lymphoblastic leukemia.
    Nagler A, Brenner B, Tatarsky I.
    Acta Haematol; 1986 Aug 01; 76(2-3):164-5. PubMed ID: 3101358
    [Abstract] [Full Text] [Related]

  • 16. Gibbs sampling for long-term survival data with competing risks.
    Chao EC.
    Biometrics; 1998 Mar 01; 54(1):350-66. PubMed ID: 9544528
    [Abstract] [Full Text] [Related]

  • 17. [Erythroderma disclosing transformation of refractory anemia with excess of blasts into lymphoblastic leukemia].
    Bodokh I, Lacour JP, Perrin C, Rosenthal E, Garnier G, Pesce A, Ortonne JP.
    Ann Dermatol Venereol; 1993 Mar 01; 120(4):303-4. PubMed ID: 8239380
    [Abstract] [Full Text] [Related]

  • 18. [Refractory anemia with excess of blasts (RAEB) with a high level of HbF that preceded apparent pancytopenia].
    Matsuda A, Kusumoto S, Ito K, Yokoo H, Maruyama T, Jinnai I, Harano T, Watanabe K, Hirashima K.
    Rinsho Ketsueki; 1996 Jan 01; 37(1):60-4. PubMed ID: 8683869
    [Abstract] [Full Text] [Related]

  • 19. Refractory anaemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival.
    Breccia M, Latagliata R, Carmosino I, Gentilini F, D'Elia GM, Levi A, Natalino F, Frustaci A, De Cuia MR, Alimena G.
    Acta Haematol; 2007 Jan 01; 117(4):221-5. PubMed ID: 17259693
    [Abstract] [Full Text] [Related]

  • 20. [Allogeneic peripheral blood stem cell transplantation for high-risk leukemia].
    Huang X, Wang F, Guo N.
    Zhonghua Yi Xue Za Zhi; 2001 Nov 25; 81(22):1348-51. PubMed ID: 11930625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.